Conformal Partial Brain Irradiation Versus Stereotactic Radiation Therapy in the Management of Resected Brain Metastases: A Retrospective Study

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2025 Feb 21

PMID 39981481

Authors

Sophia N Shah

Sohan S Shah

Gaurav Shukla

Sunjay A Shah

Affiliations

Soon will be listed here.

Abstract

Introduction: The standard of care after resection of a single brain metastasis is to treat the cavity with stereotactic radiation therapy (SRT) to minimize the risk of recurrence. However, a prospective randomized trial of SRT demonstrated higher than expected rates of local recurrence, possibly due to geographic miss. Conformal partial brain (CPB) irradiation using conventional fractionation is an alternate technique that allows a larger margin of healthy tissue to be safely irradiated, potentially decreasing the risk of tumor recurrence. We performed a retrospective chart review to compare the results between CPB and SRT treatments.

Methods And Materials: Patients receiving postoperative cranial radiotherapy within two months of a brain metastasis resection from 2015 to 2022 were eligible for this retrospective single-institution analysis. Fifty-seven patients met the eligibility criteria (SRT: n=32; CPB: n=25). SRT patients were treated using a robotic linear accelerator with a median dose of 24 Gy in 3 fractions. The median prescribed dose for the CPB group was 33 Gy in 11 fractions.

Results: The mean follow-up was 19.9 months. The crude rate of local recurrence rate was 21.9% (SRT) versus 0% (CPB) (p<0.013). The crude rate of radiation necrosis (RN) was 21.9% (SRT) versus 0% (CPB) (p<0.013). The mean cavity volume was 13 cc (SRT) versus 73 cc (CPB) (p<0.001). Most cases of RN were asymptomatic, although one patient suffered grade 4 status epilepticus.

Conclusion: In this single-institution cohort, CPB radiation therapy was statistically associated with a lower risk of both local failure and radiation necrosis as compared to SRT. Despite the cavity being much larger, none of the CPB patients suffered either local failure or radiation necrosis. Postoperative CPB irradiation may be beneficial for large cavity sizes or when it is difficult to delineate the tumor bed.

References

Tewarie I, Jessurun C, Hulsbergen A, Smith T, Mekary R, Broekman M . Leptomeningeal disease in neurosurgical brain metastases patients: A systematic review and meta-analysis. Neurooncol Adv. 2021; 3(1):vdab162. PMC: 8633671. DOI: 10.1093/noajnl/vdab162. View

Vogelbaum M, Brown P, Messersmith H, Brastianos P, Burri S, Cahill D . Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline. J Clin Oncol. 2021; 40(5):492-516. DOI: 10.1200/JCO.21.02314. View

Cox J, Stetz J, Pajak T . Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995; 31(5):1341-6. DOI: 10.1016/0360-3016(95)00060-C. View

Minniti G, Niyazi M, Andratschke N, Guckenberger M, Palmer J, Shih H . Current status and recent advances in resection cavity irradiation of brain metastases. Radiat Oncol. 2021; 16(1):73. PMC: 8051036. DOI: 10.1186/s13014-021-01802-9. View

Lowe S, Wang C, Brisco A, Whiting J, Arrington J, Ahmed K . Surgical and anatomic factors predict development of leptomeningeal disease in patients with melanoma brain metastases. Neuro Oncol. 2022; 24(8):1307-1317. PMC: 9340645. DOI: 10.1093/neuonc/noac023. View

Ahn J, Lee S, Kim S, Joo J, Yoo H, Lee S . Risk for leptomeningeal seeding after resection for brain metastases: implication of tumor location with mode of resection. J Neurosurg. 2012; 116(5):984-93. DOI: 10.3171/2012.1.JNS111560. View

Byrne J, Botticello T, Niemierko A, Shih H, Loeffler J, Oh K . Post-operative radiation therapy to the surgical cavity with standard fractionation in patients with brain metastases. Sci Rep. 2020; 10(1):6331. PMC: 7156661. DOI: 10.1038/s41598-020-63158-6. View

Atalar B, Choi C, Harsh 4th G, Chang S, Gibbs I, Adler J . Cavity volume dynamics after resection of brain metastases and timing of postresection cavity stereotactic radiosurgery. Neurosurgery. 2012; 72(2):180-5. DOI: 10.1227/NEU.0b013e31827b99f3. View

Donato J, Campigotto F, Uhlmann E, Coletti E, Neuberg D, Weber G . Intracranial hemorrhage in patients with brain metastases treated with therapeutic enoxaparin: a matched cohort study. Blood. 2015; 126(4):494-9. PMC: 4548746. DOI: 10.1182/blood-2015-02-626788. View

10.

Minniti G, Osti M, Niyazi M . Target delineation and optimal radiosurgical dose for pituitary tumors. Radiat Oncol. 2016; 11(1):135. PMC: 5057503. DOI: 10.1186/s13014-016-0710-y. View

11.

July J, Pranata R . Hypofractionated versus single-fraction stereotactic radiosurgery for the treatment of brain metastases: A systematic review and meta-analysis. Clin Neurol Neurosurg. 2021; 206:106645. DOI: 10.1016/j.clineuro.2021.106645. View

12.

Patchell R, Tibbs P, Walsh J, Dempsey R, Maruyama Y, Kryscio R . A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med. 1990; 322(8):494-500. DOI: 10.1056/NEJM199002223220802. View

13.

Posner J . Management of brain metastases. Rev Neurol (Paris). 1992; 148(6-7):477-87. View

14.

Popp I, Hartong N, Nieder C, Grosu A . PRO: Do We Still Need Whole-Brain Irradiation for Brain Metastases?. Cancers (Basel). 2023; 15(12). PMC: 10295923. DOI: 10.3390/cancers15123193. View

15.

Brown P, Jaeckle K, Ballman K, Farace E, Cerhan J, Anderson S . Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases: A Randomized Clinical Trial. JAMA. 2016; 316(4):401-409. PMC: 5313044. DOI: 10.1001/jama.2016.9839. View

16.

Cleary R, Meshman J, Dewan M, Du L, Cmelak A, Luo G . Postoperative Fractionated Stereotactic Radiosurgery to the Tumor Bed for Surgically Resected Brain Metastases. Cureus. 2017; 9(5):e1279. PMC: 5484602. DOI: 10.7759/cureus.1279. View

17.

Salkeld A, Hau E, Nahar N, Sykes J, Wang W, Thwaites D . Changes in Brain Metastasis During Radiosurgical Planning. Int J Radiat Oncol Biol Phys. 2018; 102(4):727-733. DOI: 10.1016/j.ijrobp.2018.06.021. View

18.

Gondi V, Pugh S, Tome W, Caine C, Corn B, Kanner A . Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial. J Clin Oncol. 2014; 32(34):3810-6. PMC: 4239303. DOI: 10.1200/JCO.2014.57.2909. View

19.

McTyre E, Scott J, Chinnaiyan P . Whole brain radiotherapy for brain metastasis. Surg Neurol Int. 2013; 4(Suppl 4):S236-44. PMC: 3656558. DOI: 10.4103/2152-7806.111301. View

20.

Nieder C, Grosu A, Gaspar L . Stereotactic radiosurgery (SRS) for brain metastases: a systematic review. Radiat Oncol. 2014; 9:155. PMC: 4107473. DOI: 10.1186/1748-717X-9-155. View